Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain disease staging in the clinical management of patients with multiple myeloma
- Discuss the use of bortezomib, both as monotherapy and in combination regimens, in the treatment of multiple myeloma
- Describe the role of stem cell transplantation in the clinical management of patients with multiple myeloma
- Articulate differences in treatment options and approaches for elderly vs younger patients with multiple myeloma
Topics covered include:
- Multiple Myeloma: Introduction and Background
- New Concepts in Criteria for Diagnosis, Prognosis, and Response
- Bortezomib in First-Line Therapy for ASCT-Eligible Patients
- Lenalidomide in First-Line Treatment for ASCT-Eligible Patients
- Stem Cell Transplantation in the Modern Era
- Expanding First-Line Treatment Options for Multiple Myeloma Patients Not Eligible for ASCT
- Steroid-Free Therapies
- Pegylated Liposomal Doxorubicin Combination Regimens
- Conclusions